A 38-year-old woman with acute promyelocytic leukemia (APL) presents to the emergency department with severe bleeding. She has epistaxis, gum bleeding, and petechiae over her trunk. Laboratory investigations reveal: Hb 7.2 g/dL, platelet count 15,000/µL, PT 18 s (control 12 s), aPTT 45 s (control 28 s), fibrinogen 85 mg/dL (normal 200–400), D-dimer markedly elevated at 8.5 µg/mL (normal

Question

A 38-year-old woman with acute promyelocytic leukemia (APL) presents to the emergency department with severe bleeding. She has epistaxis, gum bleeding, and petechiae over her trunk. Laboratory investigations reveal: Hb 7.2 g/dL, platelet count 15,000/µL, PT 18 s (control 12 s), aPTT 45 s (control 28 s), fibrinogen 85 mg/dL (normal 200–400), D-dimer markedly elevated at 8.5 µg/mL (normal <0.5). Peripheral blood smear shows abnormal promyelocytes with Auer rods. What is the most likely diagnosis?

Accepted Answer

C. Disseminated intravascular coagulation secondary to acute promyelocytic leukemia. ## Clinical Presentation and Diagnosis **Key Point:** DIC in APL is a medical emergency characterized by simultaneous activation of coagulation and fibrinolysis, leading to consumption of platelets, fibrinogen, and clotting factors. ### Why This Patient Has DIC This patient exhibits the classic pentad of DIC: | Finding | Value | Significance | |---------|-------|---------------| | Thrombocytopenia | 15,000/µL | Platelet consumption | | Prolonged PT/aPTT | 18 s / 45 s | Factor consumption | | Hypofibrinogenemia | 85 mg/dL | Fibrinogen consumption + fibrinolysis | | Elevated D-dimer | 8.5 µg/mL | Fibrin formation and degradation | | Clinical bleeding | Epistaxis, petechiae | Microthrombi + factor depletion | **High-Yield:** APL (t(15;17), PML-RARA fusion) is the **most common malignancy associated with DIC** at presentation. The leukemic promyelocytes release tissue factor (TF) and cancer procoagulant, triggering the extrinsic pathway. ### Pathophysiology of DIC in APL ```mermaid flowchart TD A[APL promyelocytes]:::outcome --> B[Release Tissue Factor + Cancer Procoagulant]:::action B --> C[Extrinsic pathway activation]:::action C --> D[Thrombin generation]:::outcome D --> E[Platelet consumption]:::urgent D --> F[Fibrinogen → Fibrin]:::urgent D --> G[Factor V, VIII, II consumption]:::urgent F --> H[Plasmin activation]:::action H --> I[Fibrin degradation]:::action I --> J[Elevated D-dimer & FDPs]:::outcome E --> K[Bleeding + Microthrombi]:::urgent ``` **Clinical Pearl:** The combination of **prolonged PT/aPTT + thrombocytopenia + hypofibrinogenemia + elevated D-dimer** in a patient with APL is pathognomonic for DIC. The Auer rods on smear confirm the APL diagnosis. ### ISTH Scoring for DIC This patient meets criteria for **overt DIC**: - Platelet count <100,000: 1 point - D-dimer/FDP elevation (markedly): 3 points - PT prolongation: 1 point - Fibrinogen <100 mg/dL: 1 point - **Total ≥5 points = compatible with overt DIC** **Mnemonic:** **COAGULATION** — Consumption Of All clotting factors, Organ dysfunction, Activation of coagulation, Granulocytes (leukemia), Urokinase/plasmin (fibrinolysis), Low platelets, Abnormal PT/aPTT, Tissue factor release, Increased D-dimer, Organ bleeding, Necrosis of tissues. ### Management Priority 1. **Immediate:** Fresh frozen plasma (FFP) + cryoprecipitate for factor/fibrinogen replacement 2. **Concurrent:** ATRA (all-trans retinoic acid) + chemotherapy to treat the underlying APL 3. **Avoid:** Heparin is controversial in APL-DIC (risk of hemorrhage > benefit) 4. **Monitor:** Serial PT, aPTT, fibrinogen, platelet count, D-dimer q6–12h **Warning:** Do NOT give platelet transfusions prophylactically in DIC — they may fuel thrombosis. Transfuse only if active bleeding and platelets <10,000/µL or <20,000/µL with fever/infection. [cite:Robbins 10e Ch 13] ![DIC diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/2681.webp)

Answer

A. Thrombotic thrombocytopenic purpura with coagulopathy

Answer

B. Immune thrombocytopenia with secondary fibrinolysis

Answer

D. Vitamin K deficiency with bone marrow suppression

Explanation

Clinical Presentation and Diagnosis

Why This Patient Has DIC

Pathophysiology of DIC in APL

ISTH Scoring for DIC

Management Priority

Practice similar questions

Join our NEET PG community